Nutex Health (NASDAQ:NUTX) Trading Down 7.3% – Time to Sell?

Shares of Nutex Health Inc. (NASDAQ:NUTX) traded down 7.3% on Tuesday . The stock traded as low as $162.39 and last traded at $162.9050. 46,216 shares changed hands during trading, a decline of 70% from the average session volume of 151,923 shares. The stock had previously closed at $175.78.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 8th. Finally, Maxim Group set a $205.00 target price on shares of Nutex Health and gave the company a “buy” rating in a research report on Tuesday, August 26th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health Price Performance

The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.18 and a current ratio of 3.20. The company has a market capitalization of $1.16 billion, a PE ratio of 8.87 and a beta of -0.03. The company’s 50-day simple moving average is $125.68 and its 200-day simple moving average is $112.54.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The business had revenue of $243.99 million for the quarter, compared to analyst estimates of $221.93 million.

Insider Buying and Selling at Nutex Health

In other news, CFO Jon Christian Bates bought 750 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The shares were purchased at an average price of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the transaction, the chief financial officer owned 5,638 shares in the company, valued at $770,770.98. The trade was a 15.34% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 36.92% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NUTX. State of Alaska Department of Revenue acquired a new stake in Nutex Health in the 3rd quarter valued at $30,000. BNP Paribas Financial Markets lifted its position in Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares in the last quarter. Ameritas Investment Partners Inc. purchased a new position in Nutex Health in the 2nd quarter worth approximately $44,000. Bank of America Corp DE grew its position in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after acquiring an additional 2,043 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey purchased a new stake in shares of Nutex Health during the second quarter valued at approximately $97,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.